SYNAPS Dx
PrivateLast Round
Series A
Oct 12, 2021
Total Funding Raised
$10M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
SYNAPS Dx operates in Healthcare & Life Sciences and is based in Rockville, Maryland. Its latest recorded funding round was a Series A round in October 2021.
SYNAPS Dx is a diagnostics company that researches, develops, and commercializes diagnostics for neurodegenerative disorders, including its primary product DISCERN™, a minimally invasive test for the definitive diagnosis of Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SYNAPS Dx Comparables
Compare SYNAPS Dx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CND Life Sciences | 80% | |
| C2N Diagnostics | 78% | |
| Labcorp | 72% |
For institutional investors. Book with your work email.
SYNAPS Dx Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 50% MoM.
- Aug 22, 2026
Monthly visitors increased 147% MoM, reaching 2.3K.
For institutional investors. Book with your work email.
SYNAPS Dx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SYNAPS Dx's valuation, stock price, and market status.
Is SYNAPS Dx a public or private company?
SYNAPS Dx is a private company.
What is the current stock price of SYNAPS Dx?
SYNAPS Dx is a private company, so its shares have no public market price. Caplight tracks SYNAPS Dx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SYNAPS Dx worth (valuation)?
Valuation information for SYNAPS Dx is not publicly available.
Can I buy SYNAPS Dx stock?
SYNAPS Dx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SYNAPS Dx's last funding round?
SYNAPS Dx's most recent funding round was Series A on October 12, 2021.
Who are the main investors in SYNAPS Dx?
Investor information for SYNAPS Dx is not publicly disclosed.
Will SYNAPS Dx IPO soon?
No public IPO plans have been announced for SYNAPS Dx.
How can I track SYNAPS Dx secondary market activity?
Caplight tracks bids, offers, and trades in SYNAPS Dx's shares on secondary markets.